Cancer Care Centers · Research Institutes
Dana-Farber Cancer Institute: Products & infrastructure
Dana-Farber Cancer Institute has 21 clinical trials on record, 4 under way.
Data updated Nov 22, 2026 · Back to the company report
Products
Dana-Farber Cancer Institute has 21 clinical trials on record, 4 under way.
21clinical trials
4trials under way
1in phase 3
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 13 more records
Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
phase 2 · stopped or withdrawn · as a collaborator · Mycosis Fungoides
May 2026
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
under way · 100 participants · as a collaborator · Hereditary Cancer Syndromes; Clinical Decision Support
Feb 2026
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
under way · 90 participants · as a collaborator · Hematopoietic Stem Cell Transplantation; Cancer
Oct 2024
A Study of HB0045 Injection in Patients With Advanced Solid Tumors
phase 2 · stopped or withdrawn · 71 participants · as a collaborator · Solid Tumor, Adult
Jul 2023
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
phase 1 · completed · 7 participants · as a collaborator · Multiple Myeloma
Oct 2021
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
phase 2 · under way · 28 participants · as a collaborator · High-grade Glioma; Solid Tumor, Unspecified, Child
Sep 2020
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
phase 1 · completed · 23 participants · as a collaborator · Merkel Cell Carcinoma; Cutaneous Squamous Cell Carcinoma; Non-Melanoma Skin Can…
Mar 2020
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
phase 1 · under way · 77 participants · as a collaborator · Melanoma Stage III; Melanoma Stage IV
Jun 2019
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
